2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 12.390 | 0 | 5.774 | 6.456 | 2.309 | 16.538 | 1.970 | 1.609 | 0 | 0 |
Total Income - EUR | 12.390 | 3.484 | 5.774 | 44.093 | 3.006 | 16.538 | 10.443 | 23.547 | 9.546 | 6.374 |
Total Expenses - EUR | 1.022 | 1.067 | 291 | 28.806 | 7.839 | 12.199 | 5.412 | 14.646 | 32.373 | 17.463 |
Gross Profit/Loss - EUR | 11.367 | 2.417 | 5.483 | 15.287 | -4.834 | 4.339 | 5.031 | 8.900 | -22.828 | -11.090 |
Net Profit/Loss - EUR | 11.367 | 2.417 | 5.383 | 15.261 | -4.844 | 4.339 | 4.972 | 8.852 | -22.831 | -11.090 |
Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Zoovital-Trio S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Assets | 30.466 | 33.137 | 67.056 | 16.080 | 12.875 | 16.352 | 26.349 | 35.576 | 26.084 | 181 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | 331 | 334 | 6.105 | 6.872 | 6.746 | 6.957 | 8.795 | 9.909 | 1.017 | 0 |
Cash | 30.135 | 32.803 | 60.951 | 9.208 | 6.129 | 9.396 | 17.555 | 25.667 | 25.067 | 181 |
Shareholders Funds | 30.466 | 33.137 | 38.182 | 16.080 | 10.941 | 15.067 | 19.754 | 28.168 | 5.424 | -5.682 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 0 | 0 | 28.874 | 0 | 1.934 | 1.285 | 6.595 | 7.408 | 20.660 | 5.863 |
Income in Advance | 0 | 0 | 28.874 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "111 - 111" | |||||||||
CAEN Financial Year |
142
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Zoovital-Trio S.r.l.